Consultations antérieures sur les éventuelles substances dont la substitution est envisagée et sur les conditions de dérogation

The information collected from the closed consultations is available below.

Please note that the information that has been declared confidential is not published but reserved for use only by the Biocidal Products Committee (BPC) members, the Member State Competent Authorities for BPR, the ECHA Secretariat and the European Commission.

Potential candidate for substitution previous consultation - links

There are currently no ongoing consultations.
 
CfS Dinotefuran - 165252-70-0 18 29/11/2013 28/01/2014 Details
CfS Glutaral,Glutaraldehyde,1,5-pentanedial 203-856-5 111-30-8 02, 03, 04, 06, 11, 12 17/12/2013 15/02/2014 Details
CfS Clothianidin 433-460-1 210880-92-5 18 10/02/2014 11/04/2014 Details
CfS Cybutryne 248-872-3 28159-98-0 21 10/02/2014 11/04/2014 Details
CfS Cyfluthrin 269-855-7 68359-37-5 18 10/02/2014 11/04/2014 Details
CfS Didecylmethylpoly(oxyethyl)ammonium propionate - 94667-33-1 8 10/02/2014 11/04/2014 Details
CfS Hexaflumuron (ISO),1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea 401-400-1 86479-06-3 18 10/02/2014 11/04/2014 Details
CfS N,N'-methylenebismorpholine (MBM) 227-062-3 5625-90-1 6, 13 10/02/2014 11/04/2014 Details
CfS 5-Chloro-2-(4-chlorophenoxy)-phenol (DCPP) 429-290-0 3380-30-1 1, 2, 4
11/04/2014 10/06/2014 Details
CfS Medetomidine - 86347-14-0 21 16/06/2014 15/08/2014


Details
CfS Triclosan 222-182-2 3380-34-5 1 16/06/2014 15/08/2014 Details
CfS Carbendazim 234-232-0 10605-21-7 7, 9, 10
04/07/2014 02/09/2014 Details
CfS Formaldehyde 200-001-8 50-00-0 2, 3 09/02/2015 10/04/2015 Details
CfS Polyhexamethylene biguanide with a mean number-average molecular weight (Mn) of 1600 and a mean polydispersity (D) of 1.8 (PHMB with Mn = 1600 and D = 1.8) - 27083-27-8 01, 02, 03, 04, 06, 09, 11 09/02/2015 10/04/2015 Details
CfS Brodifacoum 259-980-5 56073-10-0 14
17/12/2015 15/02/2016 Details
CfS Bromadiolone 249-205-9 28772-56-7 14
17/12/2015 15/02/2016 Details
CfS Chlorophacinone 223-003-0 3691-35-8 14 17/12/2015 15/02/2016 Details
CfS Coumatetralyl 227-424-0 5836-29-3 14 17/12/2015 15/02/2016 Details
CfS Difenacoum 259-978-4 56073-07-5 14 17/12/2015 15/02/2016 Details
CfS Difethialone - 104653-34-1 14 17/12/2015 15/02/2016 Details
CfS Flocoumafen 421-960-0 90035-08-8 14 17/12/2015 15/02/2016 Details
CfS Warfarin 201-377-6 81-81-2 14 17/12/2015 15/02/2016 Details
CfS Cyanamide 206-992-3 420-04-2 3, 18 22/02/2016 21/04/2016 Details
CfS Polyhexamethylene biguanide with a mean number-average molecular weight (Mn) of 1600 and a mean polydispersity (D) of 1.8 (PHMB with Mn = 1600 and D = 1.8) -
27083-27-8
32289-58-0
5 22/02/2016 21/04/2016 Details
CfS 3,3’-methylene-bis[5-methyloxazolidine] (Oxazolidin/MBO) [In the RAC Opinion on the CLH proposal for MBO the following name was used: Reaction product of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2)] 266-235-8 66204-44-2 2, 6, 11, 12, 13 04/11/2016 03/01/2017 Details
CfS α,α′,α″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol (HPT) [In the RAC Opinion on the CLH proposal for HPT the following name was used: Reaction product of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1)] 246-764-0 25254-50-6 2, 6, 11, 13 04/11/2016 03/01/2017 Details
CfS Acetamiprid -
135410-20-7
160430-64-8
18
18/11/2016 17/01/2017 Details
CfS Azoxystrobin - 131860-33-8 7, 9, 10
10/02/2017 10/04/2017 Details
CfS Chlorophene 204-385-8 120-32-1 2, 3 10/02/2017 10/04/2017 Details
CfS d-Allethrin - 231937-89-6 18 10/02/2017 10/04/2017 Details
CfS esbiothrin/ d-trans-allethrin 75/25 - 260359-57-7 18 10/02/2017 10/04/2017 Details
CfS PHMB (1415; 4.7) i.e. Polyhexamethylene biguanide with a mean number-average molecular weight (Mn) of 1415 and a mean polydispersity (PDI) of 4.7 -
32289-58-0
1802181-67-4
1, 2, 4, 5, 6 10/02/2017 10/04/2017 Details
CfS (RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl) cyclopropanecarboxylate (Cyphenothrin) 254-484-5 39515-40-7 18
21/04/2017 20/06/2017 Details
CfS Chlorfenapyr - 122453-73-0 18 21/04/2017 20/06/2017 Details
CfS Cholecalciferol (Vitamin D3) 200-673-2 67-97-0 14 17/07/2017 15/09/2017 Details
Derogation Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 3:2) - - 2, 6, 11, 13 04/09/2017 04/11/2017 Details
Derogation Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 3:2) - - 2, 6, 11, 12, 13 04/09/2017 04/11/2017 Details
Derogation Cholecalciferol 200-673-2 67-97-0 14 01/02/2018 01/04/2018 Details
CfS 2,2-dibromo-2-cyanoacetamide (DBNPA) 233-539-7 10222-01-2 4
20/11/2018 18/01/2019 Details
CfS Cyanamide 206-992-3 420-04-2 3, 18 26/06/2019 25/08/2019 Details
Derogation 2,2-dibromo-2-cyanoacetamide; [DBNPA] 233-539-7 10222-01-2 4 11/10/2019 10/12/2019 Details
CfS Creosote 232-287-5 8001-58-9 8 23/10/2019 22/12/2019 Details
CfS Alpha-bromadiolone
≥ 76.9% 3-[(1R,3R)-(1S,3S)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin and ≤ 23.1% 3-[(1R, 3S)-(1S,3R)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin
- - 14 14/02/2020 14/04/2020 Details
CfS Ethylene oxide 200-849-9 75-21-8 2 09/04/2020 08/06/2020 Details
CfS Boric acid 233-139-2 10043-35-3 8 28/08/2020 27/10/2020 Details
CfS Disodium tetraborate pentahydrate 215-540-4 12179-04-3 8 28/08/2020 27/10/2020 Details
Derogation Creosote 232-287-5 8001-58-9 8 29/01/2021 30/03/2021 Details
CfS 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) 262-104-4 60207-90-1 8 08/07/2021 06/09/2021


Details
CfS Hexaflumuron (ISO),1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea 401-400-1 86479-06-3 18 16/08/2021 15/10/2021

Details
Derogation 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) 262-104-4 60207-90-1 8 17/06/2022 15/08/2022 Details